Evidence map›Paper›PMID 35404983›Full record

ArticlePLoS neglected tropical diseases2022

Prevalence and factors associated with human Taenia solium taeniosis and cysticercosis in twelve remote villages of Ranomafana rainforest, Madagascar.

Anjanirina Rahantamalala, Rado Lalaina Rakotoarison, Emma Rakotomalala, Mahenintsoa Rakotondrazaka, Jaydon Kiernan, Paul M Castle, Lee Hakami, Koeun Choi, Armand Solofoniaina Rafalimanantsoa, Aina Harimanana and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Viability ofVeterinary world · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Anjanirina RahantamalalaInstitut Pasteur de Madagascar, Immunology of Infectious Diseases Unit, Antananarivo, Madagascar.ORCID 0000-0003-1219-9865
Rado Lalaina RakotoarisonInstitut Pasteur de Madagascar, Immunology of Infectious Diseases Unit, Antananarivo, Madagascar.ORCID 0000-0002-7325-9238
Emma RakotomalalaInstitut Pasteur de Madagascar, Immunology of Infectious Diseases Unit, Antananarivo, Madagascar.
Mahenintsoa RakotondrazakaInstitut Pasteur de Madagascar, Immunology of Infectious Diseases Unit, Antananarivo, Madagascar.
Jaydon KiernanRenaissance School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Paul M CastleRenaissance School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.ORCID 0000-0003-4514-0528
Lee HakamiRenaissance School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Koeun ChoiRenaissance School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Armand Solofoniaina RafalimanantsoaInstitut Pasteur de Madagascar, Helminthiasis Unit, Antananarivo, Madagascar.ORCID 0000-0001-8974-1849
Aina HarimananaInstitut Pasteur de Madagascar, Epidemiology and Clinical Research Unit, Antananarivo, Madagascar.
Patricia WrightCentre ValBio, Ranomafana, Ifanadiana, Madagascar.
Simon Grandjean LapierreGlobal Health Institute, Stony Brook University, Stony Brook, New York, United States of America.ORCID 0000-0003-3646-1573
Matthieu SchoenhalsInstitut Pasteur de Madagascar, Immunology of Infectious Diseases Unit, Antananarivo, Madagascar.ORCID 0000-0001-8928-8669
Peter M SmallCentre ValBio, Ranomafana, Ifanadiana, Madagascar.ORCID 0000-0001-5403-8985
Luis A MarcosGlobal Health Institute, Stony Brook University, Stony Brook, New York, United States of America.
Inès Vigan-WomasInstitut Pasteur de Madagascar, Immunology of Infectious Diseases Unit, Antananarivo, Madagascar.ORCID 0000-0001-7848-9297
Institut Pasteur de Madagascar · MGStony Brook School · USCentre National de la Recherche Appliquée au Developpement Rural · MGStony Brook University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfections with the tapeworm Taenia solium (taeniosis and cysticercosis) are Neglected Tropical Diseases (NTD) highly endemic in Madagascar. These infections are however underdiagnosed, underreported and their burden at the community level remains unknown especially in rural remote settings. This study aims at assessing the prevalence of T. solium infections and associated risk factors in twelve remote villages surrounding Ranomafana National Park (RNP), Ifanadiana District, Madagascar. METHODOLOGY: A community based cross-sectional survey was conducted in June 2016. Stool and serum samples were collected from participants. Tapeworm carriers were identified by stool examination. Taenia species and T. solium genotypes were characterised by PCR and sequencing of the mitochondrial cytochrome c oxidase subunit 1 (cox1) gene. Detection of specific anti-cysticercal antibodies (IgG) or circulating cysticercal antigens was performed by ELISA or EITB/Western blot assays. PRINCIPAL

findingsOf the 459 participants with paired stool and blood samples included ten participants from seven distinct villages harbored Taenia spp. eggs in their stools samples DNA sequencing of the cox1 gene revealed a majority of T. solium Asian genotype (9/10) carriage. The overall seroprevalences of anti-cysticercal IgGs detected by ELISA and EITB were quite similar (27.5% and 29.8% respectively). A prevalence rate of 12.4% of circulating cysticercal antigens was observed reflecting cysticercosis with viable cysts. Open defecation (Odds Ratio, OR = 1.5, 95% CI: 1.0-2.3) and promiscuity with households of more than 4 people (OR = 1.9, 95% CI: 1.1-3.1) seem to be the main risk factors associated with anticysticercal antibodies detection. Being over 15 years of age would be a risk factor associated with an active cysticercosis (OR = 1.6, 95% CI: 1.0-2.7). Females (OR = 0.5, 95% CI: 0.3-0.9) and use of river as house water source (OR = 0.3, 95% CI: 0.1-1.5) were less likely to have cysticercosis with viable cysts. CONCLUSIONS/SIGNIFICANCE: This study indicates a high exposure of the investigated population to T. solium infections with a high prevalence of cysticercosis with viable cysts. These data can be useful to strengthen public health interventions in these remote settings.

Indexed as

CysticercosisCystsSwine DiseasesTaeniasisTaenia soliumAnimalsCross-Sectional StudiesCysticercusFemaleHumansMadagascarNeglected DiseasesPrevalenceRainforestSwine

Identifiers

PMID35404983
PMCPMC9064101
OpenAlexW4223425069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.